BioInvent and SkylineDx to Collaborate on Patient Stratification to Maximize Impact of Treatment with BI-1206

24. März 2020 INDIZES WEUR

LUND, Sweden, March 24, 2020 /PRNewswire/ — BioInvent International AB (“BioInvent”) (OMXS: BINV) today announces an agreement with SkylineDx to characterize the gene expression and immunological …
(Orginal – Story lesen…)

Tags: atx cac ftse ibex omxs wig-20

You may also like...